Progesterone 200 mg vaginal capsules

DRUG4 trials

Sponsors

Grünenthal GmbH, Dr. Soetomo General Hospital, Medicare Hospital (Pvt) Limited, University Hospital, Ghent

Conditions

FertilityImplantation, EmbryoPregnancies at Increased Risk of Preterm BirthPregnant WomenPreterm BirthPreterm Labor With Intact Membranes

Phase 2

Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery

CompletedNCT02225353

Grünenthal GmbHPreterm Birth

Start: 2013-09-02End: 2017-03-13Updated: 2018-10-23

Phase 4

Effect of Vaginal Progesterone Treatment on Pregnancy and Newborn Outcomes in Women With Preterm Labor

CompletedNCT07523295

Medicare Hospital (Pvt) LimitedPreterm Birth, Preterm Labor With Intact Membranes

Start: 2025-05-06End: 2025-11-05Updated: 2026-04-13

Cycle-to-cycle Variability of Progesterone in the Endometrium in Patients Undergoing an Euploid Blastocyst Transfer in a Hormone Replacement Therapy (HRT) Cycle (PROMICOFET)

Not yet recruitingNCT07818278

University Hospital, GhentFertility, Implantation, Embryo

Start: 2026-10-01End: 2029-08-31Target: 70Updated: 2026-09-14

Unknown Phase

Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm Birth

CompletedNCT06975943

Dr. Soetomo General HospitalPregnancies at Increased Risk of Preterm Birth, Pregnant Women

Start: 2025-01-01End: 2026-02-28Updated: 2026-08-28